Case report of Hallervorden-Spatz disease with magnetic resonance findings;Un caso de enfermedad de Hallervorden-Spatz con hallazgos de resonancia magnetica

Revista de Investigacion Clinica

Volumn 50, Issue 3, 1998, Pages 249-253

  Ruiz Sandoval, José Luis ^a   García Ramos, Guillermo ^a,b   Vega Boada, Felipe ^b   Estañol Vidal, Bruno ^b  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Eye of tiger sign; Globus pallidus; Hallervorden Spatz disease; Storage iron

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BROMOCRIPTINE; DEFEROXAMINE; DIAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PROPRANOLOL;

ADULT; ARTICLE; AUTOPSY; AUTOSOMAL RECESSIVE DISORDER; BASAL GANGLION; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; GLOBUS PALLIDUS; HALLERVORDEN SPATZ DISEASE; HISTOPATHOLOGY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; IRON STORAGE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADULT; HALLERVORDEN-SPATZ SYNDROME; HUMANS; MAGNETIC RESONANCE IMAGING; MALE;

EID: 0031705754     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Halliday W. The nosology of Hallervorden-Spatz disease. J Neurol Sci 1995; 134 (Suppl):84-91.
2. Dooling EC, Schoene WC, Richardson EP. Hallervorden Spatz syndrome. Arch Neurology 1974; 30:70-83.
3. Higgins JJ, Patterson MC, Papadopoulos NM, Brady RO, Pentchev PG, Barton NW. Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration (HARP syndrome). Neurology 1992; 42:194-8.
4. Defendini R, Markesbery WR, Mastry AR, Duffy PE. Hallervorden-Spatz disease and infantile neuroaxonal dystrophy. Ultrastructural observations, anatomical pathology and nosology. J Neurol Sci 1973; 20:7-23.
5. Swaiman KF. Haliervorden-Spatz syndrome and brain iron metabolism. Arch Neurol 1991; 48:1285-93.
6. Ostergaard JR, Christensen T, Hansen KN. In vivo diagnosis of Hallervorden-Spatz disease. Case report. Dev Med Child Neurol. 1994; 37:827-33.
7. Morphy MA, Feldman JA, Kilburn G. Hallervorden-Spatz in a psychiatric setting. J Clin Psychiatry 1989; 50:66-8.
8. Park BE, Netsky MG, Betsill WL. Pathogenesis of pigment and spheroid formation in Hallervorden-Spatz syndrome and related disorders. Neurology 1975; 25:1172-8.
9. Perry TL, Norman MG, Yong VW, Whiting S, Crichton JU, Hansen S, et al. Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Ann Neurol 1985; 18:482-9.
10. Schaffert DA, Johnsen SD, Johnson PC, Drayer BP. Magnetic resonance imaging in pathologically proven Hallervorden-Spatz disease. Neurology 1989; 39:440-2.
11. Taylor TD, Litt M, Kramer P, Pandolfo M, Angelini L, Nardocci N, et al. Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet 1996; 14:479-81.
12. Angelini L, Nardocci N, Rumi V, Zorzi C, Strada L, Savoiardo M. Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life. J Neurol 1992; 239:417-25.
13. Yamamoto T, Kawamura J, Hashimoto S, Nkamura M, Iwamoto H, Kobashi Y, et al. Pallido-nigro-luysian atrophy, progressive supranuclear palsy and adult onset Hallervorden Spatz disease; a case of akinesia as a predominant feature of parkinsonism. J Neurol Sci 1990; 101:98-106.
14. Orrell RW, Amrolia PJ, Heald A, Cleland PG, Owen JS, Morgan-Hughes JA, et al. Acanthocytosis, retinitis pigmentosa and pallidal degeneration: a report of three patients, including the second reported case with hypoprebetalipoproteinemia (HARP syndrome). Neurology 1995; 45:487-92.
15. Albrigth AL, Barry MJ, Fasick P, Barron W, Shultz B. Continuous intrathecal baclofen infusion for symtomatic generalized dystonia. Neurosurgery 1996; 38:934-8.
16. Thajeb P. A case of Hallervorden-Spatz syndrome diagnosed antemortemly. Chin Med J 1993; 106:153-6.
17. Dooling EC, Richardon EP, Davis KR. Computed tomography in Hallervorden-Spatz disease. Neurology 1980; 30:1128-30.
18. Tennison MB, Bouldin TW, Whaley RA. Mineralization of basal ganglia detected by CT in Hallervorden-Spatz syndrome. Neurology 1988; 38:154-5.
19. Di Rocco M. Dystonia and calcification of the basal ganglia: another case. Neurology 1986; 36:306.
20. Savoiardo M, Halliday WC, Nardocci N, Strada L, D'Incerti L, Rumiani V, et al. Hallervorden-Spatz disease: MR and pathologic findings. Amer J Neuroradiol 1993; 14:155-62.
21. Kozo M, Okuno T, Ito M, Nakano S, Mikawa H, Fujisawa I, et al. MR imaging of group I of Hallervorden-Spatz disease. J Comput Assisted Tomogr 1988; 12:851-3.
22. Sethi KD, Adams RJ, Loring DW, ElGammal T. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol 1988; 24:692-4.
23. Davie CA, Barker GJ, Machado C, Miller DH, Lees AJ. Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome. Mov Disord 1997; 12:767-71.
24. Barbosa ER, Bittar MS, Bacheschi LA, Comerlatti LR, Scaff M. Precocious Parkinson's disease associated with "eye-of-the-tiger" type pallidal lesions. Arq Neuro-Psiquiatr 1995; 53:294-7.
25. Gallucci M, Cardona F, Arachi M, Splendiani A, Bozzao A, Passariello R. Case report. Follow-up MR studies in Hallervorden-Spatz disease. J Comput Assisted Tomogr 1989; 14:118-20.
26. Tsukamoto H, Inui K, Taniike M, Nishimoto J, Midorikawa M, Yoshimine T, et al. A case of Hallervorden-Spatz disease: progressive and intractable dystonia controlled by bilateral thalamotomy. Brain Dev 1992; 14:269-72.